Carl Zeiss Meditec AG (AFX.DE)
EUR 56.6
(-1.91%)
EUR 56.6
(-1.91%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 520.22 Million EUR | 35.92% |
| 2022 | 382.74 Million EUR | 33.65% |
| 2021 | 286.37 Million EUR | 0.01% |
| 2020 | 286.36 Million EUR | 6.72% |
| 2019 | 268.32 Million EUR | 8.15% |
| 2018 | 248.09 Million EUR | 5.89% |
| 2017 | 234.3 Million EUR | 12.48% |
| 2016 | 208.3 Million EUR | 9.98% |
| 2015 | 189.41 Million EUR | 9.87% |
| 2014 | 172.4 Million EUR | 16.12% |
| 2013 | 148.46 Million EUR | 3.81% |
| 2012 | 143.01 Million EUR | 7.04% |
| 2011 | 133.6 Million EUR | 12.07% |
| 2010 | 119.21 Million EUR | 20.35% |
| 2009 | 99.05 Million EUR | -16.97% |
| 2008 | 119.3 Million EUR | 17.93% |
| 2007 | 101.16 Million EUR | 79.55% |
| 2006 | 56.34 Million EUR | 4.27% |
| 2005 | 54.03 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 555.28 Million EUR | 0.0% |
| 2024 Q3 | - EUR | -100.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q2 | 441.4 Million EUR | 0.0% |
| 2023 Q4 | 520.22 Million EUR | 0.0% |
| 2023 FY | 520.22 Million EUR | 35.92% |
| 2022 FY | 382.74 Million EUR | 33.65% |
| 2022 Q4 | 382.74 Million EUR | 0.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q2 | 328.86 Million EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 FY | 286.37 Million EUR | 0.01% |
| 2021 Q2 | 274.07 Million EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 286.37 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2020 Q4 | 286.36 Million EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 FY | 286.36 Million EUR | 6.72% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 317.43 Million EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q4 | 268.32 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 268.32 Million EUR | 8.15% |
| 2019 Q2 | 270.7 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q4 | 248.09 Million EUR | 0.0% |
| 2018 FY | 248.09 Million EUR | 5.89% |
| 2018 Q2 | 247.47 Million EUR | 0.0% |
| 2017 Q2 | 229.41 Million EUR | 0.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 FY | 234.3 Million EUR | 12.48% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 234.3 Million EUR | 0.0% |
| 2016 Q2 | 201.65 Million EUR | -1.41% |
| 2016 FY | 208.3 Million EUR | 9.98% |
| 2016 Q1 | 204.53 Million EUR | 7.98% |
| 2016 Q4 | 208.3 Million EUR | -3.54% |
| 2016 Q3 | 215.94 Million EUR | 7.09% |
| 2015 Q2 | 205.41 Million EUR | 10.86% |
| 2015 Q4 | 189.41 Million EUR | -9.15% |
| 2015 FY | 189.41 Million EUR | 9.87% |
| 2015 Q3 | 208.48 Million EUR | 1.49% |
| 2015 Q1 | 185.28 Million EUR | 7.47% |
| 2014 Q2 | 161.55 Million EUR | -0.41% |
| 2014 Q4 | 172.4 Million EUR | -0.92% |
| 2014 FY | 172.4 Million EUR | 16.12% |
| 2014 Q1 | 162.22 Million EUR | 9.27% |
| 2014 Q3 | 174 Million EUR | 7.7% |
| 2013 Q3 | 157.25 Million EUR | 4.07% |
| 2013 Q4 | 148.46 Million EUR | -5.59% |
| 2013 FY | 148.46 Million EUR | 3.81% |
| 2013 Q1 | 145.99 Million EUR | 2.09% |
| 2013 Q2 | 151.11 Million EUR | 3.5% |
| 2012 Q4 | 143.01 Million EUR | -6.56% |
| 2012 Q2 | 140.43 Million EUR | -0.95% |
| 2012 Q3 | 153.05 Million EUR | 8.99% |
| 2012 FY | 143.01 Million EUR | 7.04% |
| 2012 Q1 | 141.78 Million EUR | 6.12% |
| 2011 Q1 | 126.45 Million EUR | 6.08% |
| 2011 FY | 133.6 Million EUR | 12.07% |
| 2011 Q4 | 133.6 Million EUR | -3.66% |
| 2011 Q3 | 138.68 Million EUR | 4.8% |
| 2011 Q2 | 132.32 Million EUR | 4.64% |
| 2010 Q4 | 119.21 Million EUR | -4.36% |
| 2010 FY | 119.21 Million EUR | 20.35% |
| 2010 Q3 | 124.64 Million EUR | 16.31% |
| 2010 Q1 | 98.04 Million EUR | -1.02% |
| 2010 Q2 | 107.17 Million EUR | 9.3% |
| 2009 FY | 99.05 Million EUR | -16.97% |
| 2009 Q4 | 99.05 Million EUR | 0.0% |
| 2008 FY | 119.3 Million EUR | 17.93% |
| 2007 FY | 101.16 Million EUR | 79.55% |
| 2006 FY | 56.34 Million EUR | 4.27% |
| 2005 FY | 54.03 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 138.94 Million EUR | -274.418% |
| Fielmann Aktiengesellschaft | 224.74 Million EUR | -131.48% |
| Gerresheimer AG | 323.34 Million EUR | -60.89% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 49.824% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 49.824% |